Baskhanbio Pharma Inc. (XKON:354390)
South Korea · Delayed Price · Currency is KRW 5,030.00
-60.00 (-1.18%)
At close: Apr 17, 2026
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 35.3 billion as of April 17, 2026. Its market cap has increased by 18.49% in one year.
Market Cap
35.30B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,030.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 35.30B, a decrease of -57.37%. That is a compound annual growth rate of -20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 35.30B | 5.23% |
| Dec 30, 2025 | 33.55B | 11.42% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
| Jul 20, 2022 | 82.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RP Bio | 55.46B |
| Eagle Veterinary Technology Co.,Ltd | 50.25B |
| Korean Drug | 46.05B |
| HLscience | 42.22B |
| GeneBioTech Co. ,Ltd | 42.06B |
| Seoul Pharma | 33.81B |
| ChoA Pharmaceutical Co., LTD. | 30.17B |
| Daesung Microbiological Labs. | 29.26B |